Belgium· BE-AMP-SAM301323-00
Januvia 100 mg
A sitagliptin product containing sitagliptin phosphate monohydrate, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 19 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Sitagliptin is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Sitagliptin · ATC A10BH01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sitagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sitagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.47
- IT Italy$1.78
- ES Spain$1.08
- FR France$0.65
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Sitagliptin Phosphate Monohydrate
- Manufacturer
- Merck Sharp & Dohme
- Country
- Belgium (BE)
- ATC code
- A10BH01
- ATC class
- Sitagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 8
3 priced- be_apb2408763EUR 21.7
- be_apb2408771EUR 57.01
- be_apb4679122EUR 42.52
- be_apb0787622
- be_apb2421998
- be_apb7729866
- be_apb4201885
- be_apb7739048
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
341 interactions on record for sitagliptin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sitagliptin · interactions on record
341 records
- 3 severe
- 292 moderate
- 44 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sitagliptin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANAUHeaton k.s., Praha
- SpainALTUXERIN 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGBexal Farmaceutica S.A.
- PolandAdimuplanSandoz GmbH
- NetherlandsAdimuplan 100 mg, filmomhulde tablettenSandoz B.V.
- SwedenAxavel 100 mg Filmdragerad tablettGenepharm S.A.
- FinlandFineriaMedical Pharmaquality SA
- ItalyADAGLIPADAMED S.R.L.
- FranceJANUVIA 100 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Jansitin, Jazeta
- Bulgaria · Sitagliptin Grindeks, Майсиглу
- Cyprus · Jidinum, Jimandin
- Czechia · Anau, Ansifora
- Germany · Frekidir, Jansitin
- Denmark · Frekidir, Meliglix
- Estonia · Adimuplan, Maysiglu
- Spain · Altuxerin, Disit
- Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
- France · Sitagliptine Adamed, Sitagliptine Almus
- United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
- Greece · Adimuplan, Axavel
- Croatia · Adimuplan, Condias
- Hungary · Ansifora, Jaglix
- Ireland · Sitagliptin Grindeks, Sitagliptin Krka
- Iceland · Januvia, Ristaben
- Italy · Adaglip, Andamane
- Liechtenstein · Januvia, Ristaben
- Lithuania · Adimuplan, Jimandin
- Luxembourg · Sitagliptin Eg
- Latvia · Adimuplan, Jimandin
- Malta · Anau, Jidinum
- Netherlands · Adimuplan, Anau
- Norway · Frekidir, Januvia
- Poland · Ansifora, Jansitin
- Portugal · Itam, Jidinum
- Romania · Adimuplan, Jansitin
- Sweden · Axavel, Frekidir
- Slovenia · Adimuplan, Maysiglu
- Slovakia · Adimuplan, Anau
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/abc80b60-472d-44f4-a095-f3918cb01216 GET /v1/drugs/abc80b60-472d-44f4-a095-f3918cb01216?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Januvia 100 mg",
"name_fr": "Januvia 100 mg",
"name_nl": "Januvia 100 mg",
"amp_code": "SAM301323-00",
"strengths": [
"100.0000",
"100.0000"
],
"pack_count": 10,
"substances": [
"Sitagliptin Phosphate Monohydrate",
"Sitagliptin",
"Sodium Stearyl Fumarate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Sitagliptin",
"authorisation_numbers": [
"EU/1/07/383/013",
"EU/1/07/383/014",
"EU/1/07/383/015",
"EU/1/07/383/016",
"EU/1/07/383/017",
"EU/1/07/383/018",
"EU/1/07/383/023",
"EU/1/07/383/024"
]
}See everything about sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.